MB "Biodrogaspa.lt" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2020 |
---|
46,761 |
- |
2,903 |
2,758 |
- |
0.10 |
1.19 |
53.58 |
5.90 |
4,868 |
5,792 |
0 |
10,660 |
2021 |
---|
43,207 |
- |
80 |
76 |
- |
0.11 |
0.36 |
50.69 |
0.18 |
4,944 |
1,804 |
0 |
6,748 |
2022 |
---|
37,836 |
- |
328 |
312 |
- |
0.14 |
0.88 |
50.36 |
0.82 |
5,256 |
4,633 |
0 |
9,889 |
Register and
explore Okredo data2022 |
---|
37,836 |
- |
328 |
312 |
- |
0.14 |
0.88 |
50.36 |
0.82 |
5,256 |
4,633 |
0 |
9,889 |
Register and
explore Okredo data2022
Turnover (€)
37,836 €-12 % *
Sales per employee (€)
-Profit before tax (€)
328 €310 % *
Net Profit (€)
312 €311 % *
Profit per employee (€)
-Working capital requirement
0.14 27.27 % *
Debt-to-equity ratio
0.88 144.44 % *
Total profitability (%)
50.36 %-0.65 % *
Net profitability (%)
0.82 %355.56 % *
Equity (€)
5,256 €6 % *
Amounts Payable And Liabilities (€)
4,633 €157 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
9,889 €47 % *